Skip to content
Screener

G&A at other companies

Teladoc Health logo
Teladoc HealthTDOC
$104.03M-3.8%
Viking Therapeutics logo
Viking TherapeuticsVKTX
$13.98M-0.7%
AdaptHealth logo
AdaptHealthAHCO
$95.91M+10.4%
LifeMD, Inc. logo
LifeMD, Inc.LFMD
$15.18M+5.8%
VAN
Vivani MedicalVANI
$2.43M+3.7%

Other financials

Income statement

See full
Revenue$87.8M+43.1%
Gross profit$63.8M+58.3%
Operating income$3.5M+182%
Net income$5.3M+200%
EPS (diluted)$0.08+133%

Balance sheet

See full
Cash & equivalents$221.7M-0.6%
Total debt$30.0M
Total equity$252.7M+18.0%
Total assets$328.2M+8.3%

Cash flow

See full
Operating cash flow-$11.8M+26.6%
CapEx$146.0K-46.1%
Free cash flow-$11.9M+27.5%

Valuation

See full
Market cap$1.16B+5.0%
P/S3.8×-1.5×

Profitability

See full
Gross margin68.2%+4.8pp
Operating margin-9.6%-4.0pp
Net margin-11.3%-4.6pp
FCF margin-40.8%

Returns & leverage

See full
Return on equity-2.6%
Debt / equity0.1×
Current ratio3.9×-0.8×

Where this comes from

Reported directly by Omada Health in its filing.

Tagged under the XBRL concept us-gaap:GeneralAndAdministrativeExpense.

The source filing: Omada Health’s 10-Q, filed August 7, 2026.

Filed
Aug 7, 2026, 4:13 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-054840
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Operating expenses
Research and development (4)14,62510,02427,32218,830
Sales and marketing (5)29,88822,31856,67542,488
General and administrative (6)15,72512,30829,71523,628
Total operating expenses60,23844,650113,71284,946
Operating income (loss)3,549(4,344)(1,232)(12,740)
Other income (expense), net
Interest expense(14)(1,094)(32)(2,168)

Item 1. Financial Statements

FAQ

What is Omada Health's G&A?
Omada Health (OMDA) reported G&A of $15.73M in Q2 2026.
How has Omada Health's G&A changed year-over-year?
Omada Health's G&A increased by 27.8% year-over-year, from $12.31M to $15.73M.
What is the long-term trend for Omada Health's G&A?
Over 2 years (2023 to 2025), Omada Health's G&A has grown at a 20.4% compound annual growth rate (CAGR), from $35.98M to $52.18M.
What does G&A mean?
Overhead costs not directly tied to production or sales — corporate management, legal, accounting, office rent, insurance, and other administrative functions.

Ask your AI about Omada Health's g&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude